Caspase inhibition prevents cardiac dysfunction and heart apoptosis in a rat model of sepsis

American Journal of Respiratory and Critical Care Medicine

Volumn 163, Issue 1, 2001, Pages 218-225

  Neviere R ^a   Fauvel, H ^a   Chopin, C ^a   Formstecher, P ^a   Marchetti, P ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE; CASPASE INHIBITOR; CYTOCHROME C; DNA FRAGMENT; ENDOTOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME RELEASE; HEART DISEASE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; SEPSIS;

EID: 0035154684     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.163.1.2003109     Document Type: Article

References (33)

1. A circulating myocardial depressant substance in humans with septic shock: Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance
2. Predictors of outcome from critical illness: Shock and cardiopulmonary resuscitation
3. Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans
4. Pathophysiology and treatment of septic shock
5. Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum
6. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock
7. Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration
8. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes: Involvement of the sphingolipid signaling cascade in cardiac cell death
9. Sphingosine mediates the immediate negative inotropic effects of TNF in the adult mammalian cardiomyocytes
10. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart
11. Cardiodepression by tumor necrosis factor-alpha
12. TNF-alpha and IL-1 alpha inhibit both pyruvate dehydrogenase activity and mitochondrial function in cardiomyocytes: Evidence for primary impairment of mitochondrial function
13. LPS-induced TNF-alpha release from and apoptosis in rat cardiomyocytes: Obligatory role for CD14 in mediating the LPS response
14. The central executioners of apoptosis: Caspases or mitochondria?
15. Apoptotic pathways: The roads to ruin
16. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
17. Quantitative assessment of cardiac myocyte apoptosis in tissue sections using the fluorescence-based tunel technique enhanced with counterstains
18. Method for quantification of myocardial infarction and inflammatory cell infiltration in rat cardiac tissue
19. LPS pretreatment ameliorates peritonitis-induced myocardial inflammation and dysfunction: Role of myocytes
20. Activation of caspase 3 (CPP32)-like proteases is essential for TNF-alpha-induced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine endotoxin shock model
21. TNF-induced enterocyte apoptosis in mice is mediated by the TNF receptor 1 and does not require p53
22. Apoptosis in cardiovascular disease
23. Modes of myocardial cell injury and cell death in ischemic heart disease
24. Myocardial cell injury in septic shock
25. Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function
26. Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally
27. Apoptosis in heart failure: Release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy
28. The mitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes
29. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor
30. Extended therapeutic window for caspase inhibition and synergy with MK-801 in the treatment of cerebral histotoxic hypoxia
31. Caspase activation without death
32. Caspases and cytokines: Roles in inflammation and autoimmunity
33. Stimulation of CD95 (Fas) blocks T lymphocyte calcium channels through sphingomyelinase and sphingolipids